Myo-Inositol for Blood Sugar Regulation

Research suggests that myo-inositol may play a role in blood sugar regulation, though the available evidence linked here is preliminary and context-specific. One study is a registered clinical trial protocol — not yet a completed trial — designed to test whether myo-inositol supplementation during pregnancy can reduce gestational diabetes risk in women with PCOS, meaning no results from that investigation are yet available, though the researchers note earlier broader-population trials showed promising signals. A separate mechanistic laboratory study examined calcium signaling pathways in pancreatic cells and, while focused primarily on vasopressin rather than inositol directly, identified the IP3 receptor — a signaling protein closely tied to inositol metabolism — as relevant to how beta cells regulate insulin release. Taken together, the linked evidence reflects early-stage and indirect research directions rather than established findings, and stronger conclusions about myo-inositol's effects on blood sugar will depend on the outcomes of completed clinical trials.